a translator and interpreter by training, i specialized in medical translation and communications soon after graduating from university in both vienna, austria and monterey, california.
why medicine? inspired and motivated by my husband who now is a medical doctor in private practice, i ventured into this vast, challenging, and fascinating subject-matter area and started wrapping my head around itâ€”a process that has never stopped since.
the text clinic allows me to combine my life-long fascination with the english language with my experience in designing a wide range of biomedical text types to support cutting-edge research organizations in their communication goals.
before foundingÂ the text clinic in 2006, i held various positions as a healthcare communicator, most recently as medical writer in the international clinical development department that brought forth the worldâ€™s first biosimilar.
a stint into the software industry as technical writer and a position as multilingual translation manager and lead translator have rounded off my IT and documentation expertise.
today, i am looking back on close to 30 years of professional experience and countless documents that have left my desk. and looking forward to many moreâ€¦
far and away the best prize that life has to offer is the chance to work hard at work worth doing
theodore roosevelt (1858âˆ’1919),Â US president
gesellschaft fÃ¼r pharmazeutische
Kainz JT, Berghammer G, Auer-Grumbach P, Lackner V, Perl-Convalexius S, Popa R et al.: Azelaic acid 20 % cream: effects on quality of life and disease severity in adult female acne patients. J Dtsch Dermatol Ges 2016,14:1249â€“59.
Farkas M. 8-year-sustained response in a patient with isolated del(5q) myelodysplastic syndrome undergoing continuous treatment with lenalidomide: a case report. memo â€“ Magazine of European Medical Oncology 2016,9:48â€“51. link to abstract
Stemberger M, Schmit E, Kurnik K, Spannagl M. Motivational effects of top-rope climbing therapy under individualized prophylaxis: a pilot study in young adults with severe haemophilia. Haemophilia 2015,21:504â€“7.
Conference report on the 14th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Tick-Borne Encephalitis (TBE): A Risk Still Underestimated. 2â€“3 February 2012, Vienna, Austria. link to fulltext
Zuber Z, Rutkowska-Sak L, Postepski J et al. Etanercept treatment in juvenile idiopathic arthritis: the Polish registry. Med Sci Monit 2011;17:35â€“42.
Loew-Baselli A, Poellabauer EM, Pavlova BG et al. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years. Hum Vaccin 2009;5:551â€“6.
Jilkova E, Vejvalkova P, Stiborova I et al. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly-results from an observational study. Expert Opin Biol Ther 2009,9:797â€“803.
Ebner W, Palotai T, Codreanu C et al. [Ankylosing spondylitis in Central and Eastern Europe : Cross-sectional study on treatment modalities, disease activity and quality of life.] Z f Rheumat 2008;67:503â€“10.
Romer T, Peter F, Saenger P et al. Efficacy and safety of a new ready-to-use recombinant human growth hormone solution. Journal of Endocrinological Investigation 2007,30:578â€“89.
Kainz JT, Berghammer G, Auer-Grumbach P, Lackner V, Perl-Convalexius S, Popa R et al.: Azelainsaure 20 % Creme: Auswirkung auf Lebensqualitat und Krankheitsaktivitat bei erwachsenen Patientinnen mit Acne vulgaris. J Dtsch Dermatol Ges 2016;14:1249â€“60.